|
⚲
|
| Keyboard |
| Jayagopal Ashwath
✚
|
|
|---|---|
| CIK # | 0002008983 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002008983] | |
| 4 | [0002008983] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Jayagopal Ashwath | |
| Rexahn Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-03-16 | Sell | 3,719 | $5.12 | 19,041 |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-02-12 | Tax withheld | 5,313 | $3.39 | 18,011 |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-01-22 | Grant | 400,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-03-13 | Grant | 52,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Employee Stock Option (right to buy) · derivative
|
2025-03-13 | Grant | 52,500 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-02-13 | Tax withheld | 5,193 | $1.15 | 5,972 |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-05-22 | Buy | 3,500 | $1.77 | 6,195 |
|
Rexahn Pharmaceuticals Inc OCUP
Employee Stock Option (right to buy) · derivative
|
2024-02-12 | Grant | 225,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc OCUP
Common Stock
|
2024-02-12 | Grant | 75,000 | $0.00 |